SEC Form 4 · accession 0001645627-17-000014
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Feb 9, 2017
Accepted (ET)
Mar 2, 2017 · 8:23 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 9, 2017 | P | 1,000 | $0.0165 | A | 19,739,249 | D | |
| Common Stock | Feb 9, 2017 | P | 1,000 | $0.016 | A | 19,740,249 | D | |
| Common Stock | Feb 9, 2017 | P | 200 | $0.0163 | A | 19,740,449 | D | |
| Common Stock | Feb 13, 2017 | P | 1,000 | $0.017 | A | 19,741,449 | D | |
| Common Stock | Feb 13, 2017 | P | 200 | $0.016 | A | 19,741,649 | D | |
| Common Stock | Feb 13, 2017 | P | 500 | $0.0149 | A | 19,742,149 | D | |
| Common Stock | Feb 13, 2017 | P | 1,000 | $0.0155 | A | 19,743,149 | D | |
| Common Stock | Feb 13, 2017 | P | 1,000 | $0.0154 | A | 19,744,149 | D | |
| Common Stock | Feb 13, 2017 | P | 200 | $0.0139 | A | 19,744,349 | D | |
| Common Stock | Feb 13, 2017 | P | 1,000 | $0.014 | A | 19,745,349 | D | |
| Common Stock | Feb 13, 2017 | P | 500 | $0.0154 | A | 19,745,849 | D | |
| Common Stock | Feb 13, 2017 | P | 500 | $0.0154 | A | 19,746,349 | D | |
| Common Stock | Feb 13, 2017 | P | 1,000 | $0.0151 | A | 19,747,349 | D | |
| Common Stock | Feb 13, 2017 | P | 500 | $0.0154 | A | 19,747,849 | D | |
| Common Stock | Feb 13, 2017 | P | 1,000 | $0.0134 | A | 19,748,849 | D | |
| Common Stock | Feb 13, 2017 | P | 1,000 | $0.013 | A | 19,749,849 | D | |
| Common Stock | Feb 13, 2017 | P | 200 | $0.013 | A | 19,750,049 | D | |
| Common Stock | Feb 13, 2017 | P | 200 | $0.0129 | A | 19,750,249 | D | |
| Common Stock | Feb 13, 2017 | P | 1,000 | $0.0129 | A | 19,751,249 | D | |
| Common Stock | Feb 13, 2017 | P | 200 | $0.0129 | A | 19,751,449 | D | |
| Common Stock | Feb 14, 2017 | P | 500 | $0.012 | A | 19,751,949 | D | |
| Common Stock | Feb 14, 2017 | P | 1,000 | $0.0129 | A | 19,752,949 | D | |
| Common Stock | Feb 14, 2017 | P | 1,000 | $0.0129 | A | 19,753,949 | D | |
| Common Stock | Feb 14, 2017 | P | 1,000 | $0.0119 | A | 19,754,949 | D | |
| Common Stock | Feb 14, 2017 | P | 1,000 | $0.0119 | A | 19,755,949 | D | |
| Common Stock | Feb 14, 2017 | P | 200 | $0.011 | A | 19,756,149 | D | |
| Common Stock | Feb 14, 2017 | P | 1,000 | $0.011 | A | 19,757,149 | D | |
| Common Stock | Feb 14, 2017 | P | 500 | $0.011 | A | 19,757,649 | D | |
| Common Stock | Feb 14, 2017 | P | 200 | $0.0108 | A | 19,757,849 | D | |
| Common Stock | Feb 14, 2017 | P | 500 | $0.011 | A | 19,758,349 | D |
Table II — derivative securities
No Table II lines on this filing.